← Back to Influence Map
Entity DossierOrganization
HARMONY BIOSCIENCES
PA · US
pharmaceuticals
Tracked direct giving
$0
LDA reported lobbying spend
$1,685,000
Connections
6
Lobbying Activity Detail
Disclosed lobbying expenditures from LDA filings where this entity is the client. Dollar amounts represent what was reported to the Senate Office of Public Records.
Top Lobbying Issues
HCRHealth Issues
$2.2MPHAPharmacy
$1.6MMMMMedicare/Medicaid
$880KINSInsurance
$170KLobbying Firms Retained
In-house lobbyists (filed as its own registrant)$2.2M
BROWNSTEIN HYATT FARBER SCHRECK, LLP$460K
HARPER & BAILEY GOVERNMENTAL SOLUTIONS LLC$240K
THORN RUN PARTNERS$200K
LMH STRATEGIC SOLUTIONS$160K
Watkins & Eager, PLLC$105K
Lobbying data from Senate LDA filings and the LobbyView dataset (MIT/NSF, CC-BY-4.0). Dollar figures represent disclosed expenditures only and may not capture all influence activity. Issue codes follow the LDA general issue classification.
Connection Graph
0 nodes · 0 edgesHover for labels · Double-click to expand
Loading graph...
Person
Organization
PAC
Gov Body
Legislature
Think Tank
Industry
Outcome
Click a node to see details
Double-click to expand its connections
Relationships
| Type | Connected To | Details | Source |
|---|---|---|---|
| Retained | Watkins & Eager, PLLC | Hired WATKINS & EAGER PLLC to lobby on Pharmaceuticals | Source |
| Lobbied on | Sugar Reform Act (S.832, 118th Congress) | LDA filing: lobbied on Sugar Reform Act, period 2nd Quarter (Apr 1 - June 30), reported amount $150,000 | Source |
| Retained | THORN RUN PARTNERS | Hired THORN RUN PARTNERS to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |
| Retained | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Hired BROWNSTEIN HYATT FARBER SCHRECK, LLP to lobby (4th Quarter (Oct 1 - Dec 31) 2023) | Source |
| Retained | HARPER & BAILEY GOVERNMENTAL SOLUTIONS LLC | Hired HARPER & BAILEY GOVERNMENTAL SOLUTIONS LLC to lobby (4th Quarter (Oct 1 - Dec 31) 2024) | Source |
| Retained | LMH STRATEGIC SOLUTIONS | Hired LMH STRATEGIC SOLUTIONS to lobby (3rd Quarter (July 1 - Sep 30) 2025) | Source |